Inventor · disambiguated record
Wiegand Lang
Also filed as: LANG WIEGAND
11 granted patents·6 pending applications·47 citations·filing 1999–2016
87Inventor score
Top patents by PatentIndex Score
17 records- 0188US8575104B2Factor VIII, von willebrand factor or complexes thereof with prolonged in vivo half-lifeWEIMER THOMAS·Filed 2009·Granted Nov 5, 2013·18 cites·27 claims
- 0284US8765915B2Modified coagulation factor VIIa with extended half-lifeWEIMER THOMAS·Filed 2007·Granted Jul 1, 2014·8 cites·13 claims
- 0383US6831167B2Mutants of the factor VII-activating protease and detection methods using specific antibodiesAVENTIS BEHRING GMBH·Filed 2001·Granted Dec 14, 2004·9 cites·6 claims
- 0479US7153679B2Marburg I mutant of factor VII activating protease (FSAP) as risk factor for arterial thrombosisAVENTIS BEHRING GMBH·Filed 2003·Granted Dec 26, 2006·9 cites·20 claims
- 0568US9290561B2Factor VIII, von Willebrand factor or complexes thereof with prolonged in vivo half-lifeWEIMER THOMAS·Filed 2013·Granted Mar 22, 2016·1 cites·31 claims
- 0665US7863009B2Mutants of the factor VII-activating protease and detection methods using specific antibodiesCSL BEHRING GMBH·Filed 2008·Granted Jan 4, 2011·0 cites·8 claims
- 0763US7442514B2Mutants of the factor VII-activating protease and detection methods using specific antibodiesCSL BEHRING GMBH·Filed 2004·Granted Oct 28, 2008·0 cites·19 claims
- 0857US2014248686A1Therapeutic polypeptides with increased in vivo recoveryCSL BEHRING GMBH·Filed 2014·Application pending·0 cites
- 0956US7803569B2Marburg I mutant of factor VII activating protease (FSAP) as risk factor for arterial thrombosis and methods of detecting FSAP and FSAP mutationsCSL BEHRING GMBH·Filed 2006·Granted Sep 28, 2010·0 cites·20 claims
- 1056US2014356346A1MODIFIED COAGULATION FACTOR VIIa WITH EXTENDED HALF-LIFECSL BEHRING GMBH·Filed 2014·Application pending·0 cites
- 1156US2010222554A1Method of Increasing the In Vivo Recovery of Therapeutic PolypeptidesWEIMER THOMAS·Filed 2007·Application pending·0 cites
- 1255US6835817B2Monoclonal antibody which is specific for activated coagulation factor VII, and its useZLB BEHRING GMBH·Filed 2002·Granted Dec 28, 2004·0 cites·8 claims
- 1354US2013337532A1Therapeutic polypeptides with increased in vivo recoveryWEIMER THOMAS·Filed 2013·Application pending·0 cites
- 1449US2017080061A1MODIFIED COAGULATION FACTOR VIIa WITH EXTENDED HALF-LIFECSL BEHRING GMBH·Filed 2016·Application pending·0 cites
- 1543US7829095B2Inhibitory monoclonal antibody against blood clotting factor VII-activating proteaseCSL BEHRING GMBH·Filed 2003·Granted Nov 9, 2010·0 cites·2 claims
- 1642US2004161810A1Monoclonal antibodies specific for latent antithrombin III and the use thereofFiled 2003·Application pending·0 cites
- 1740US6479245B1Monoclonal antibody which is specific for activated coagulation factor VII, and its useAVENTIS BEHRING GMBH·Filed 1999·Granted Nov 12, 2002·2 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Wiegand Lang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →